Search

Displaying results 5211 - 5220 of 10000 in total
  1. Drug

    Darbinurad

    go.drugbank.com/drugs/DB21695
    Experimental

    Darbinurad has a monoisotopic molecular weight of 324.09 Da. … Darbinurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Darbinurad is a urate transporter inhibitor.

  2. Drug

    Remlifanserin

    go.drugbank.com/drugs/DB21707
    Experimental

    Remlifanserin has a monoisotopic molecular weight of 429.22 Da. … Remlifanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Remlifanserin is a serotonin receptor antagonist.

  3. Drug

    Envudeucitinib

    go.drugbank.com/drugs/DB21716
    Investigational

    Envudeucitinib has a monoisotopic molecular weight of 426.23 Da. … Envudeucitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Envudeucitinib is a Janus kinase inhibitor.

  4. Drug

    Zemprocitinib

    go.drugbank.com/drugs/DB21719
    Experimental

    Zemprocitinib has a monoisotopic molecular weight of 345.13 Da. … Zemprocitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Zemprocitinib is a Janus kinase inhibitor.

  5. Drug

    Dantrolene

    go.drugbank.com/drugs/DB01219
    ApprovedInvestigational

    Chemically, dantrolene is a hydantoin derivative, but does not exhibit antiepileptic activity like other hydantoin derivates such as phenytoin.

  6. Drug

    Selexipag

    go.drugbank.com/drugs/DB11362
    ApprovedInvestigational

    PAH is a relatively rare disease with usually a poor prognosis requiring more treatment options to prolong long-term outcomes. … Marketed by Actelion Pharmaceuticals under brand name Uptravi, selexipag and its active metabolite, ACT-333679 (MRE-269), act as agonists of the prostacyclin receptor to increase vasodilation in the pulmonary

  7. Drug

    Darbepoetin alfa

    go.drugbank.com/drugs/DB00012
    ApprovedInvestigational

    Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.

    Products: ARANESP 20UG FS MIT ANS, ARANESP 100UG FS MIT ANS
  8. Drug

    Dihydromorphine

    go.drugbank.com/drugs/DB01565
    ExperimentalIllicit

    A semisynthetic analgesic used in the study of narcotic receptors. It has abuse potential. [PubChem]

  9. Drug

    Remibrutinib

    go.drugbank.com/drugs/DB16852
    ApprovedInvestigational

    Remibrutinib is a selective Bruton's tyrosine kinase inhibitor. The FDA approved remibrutinib on September 30, 2025 as the only oral, targeted treatment for chronic spontaneous urticaria. … [L54101] Bruton's tyrosine kinase plays a role in B cell receptor and Fc receptor signalling, releasing histamine and pro-inflammatory mediators.

  10. Drug

    Octenidine

    go.drugbank.com/drugs/DB12624
    Investigational

    Octenidine is under investigation in clinical trial NCT02697162 (Antiseptic-coated Intermittent Urinary Catheter).

    Mixtures: Linola sept 1 mg/g + 20 mg/g Wund-Spray zur Anwendung auf der Haut, Lösung